Dr. Chauncey Crandall joined “Bianca Across the Nation” to discuss the benefits of Lipfendra, a daily pill recently approved by the FDA designed to dramatically lower bad cholesterol by nearly 60%.
The Food and Drug Administration (FDA) has approved a new pill that lowers cholesterol.
The Food and Drug Administration has approved a cholesterol-lowering daily pill called Lipfendra, expanding treatment possibilities beyond statins and injectables. PULSE POINTS WHAT HAPPENED: - DETAIL: On Thursday, the FDA approved Lipfendra , a new cholesterol-lowering pill. Developed by Merck, a German pharmaceutical multinational, Lipfendra belongs to the PCSK9 inhibitor class of medications. PCSK9 is a liver-produced enzyme that regulates blood cholesterol levels. The pill is the first of its kind, as previous PCSK9 inhibitors were only available as injections. The pill is designed to be taken daily. Lipfendra is intended to help patients with hypercholesterolemia, or high LDL, known widely as “bad” cholesterol. According to…Open
Clinical trials have shown that Lipfendra can bring levels of LDL, the bad type of cholesterol, down 60%.
The Food and Drug Administration approved a new sunscreen ingredient in the U.S. for the first time in 20 years. It's been used for decades in Europe and Asia.